X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3779) 3779
Publication (554) 554
Book Review (97) 97
Book Chapter (55) 55
Newspaper Article (41) 41
Newsletter (11) 11
Conference Proceeding (10) 10
Magazine Article (7) 7
Book / eBook (6) 6
Dissertation (6) 6
Reference (6) 6
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2222) 2222
serotonin (2063) 2063
neurosciences (1833) 1833
animals (1770) 1770
humans (1658) 1658
male (1261) 1261
psychiatry (1255) 1255
pharmacology & pharmacy (985) 985
rats (702) 702
brain (690) 690
anxiety (653) 653
dopamine (637) 637
female (636) 636
depression (632) 632
antidepressants (597) 597
mice (584) 584
serotonin - metabolism (540) 540
clinical neurology (491) 491
neurology (479) 479
glutamate (426) 426
neurons (416) 416
article (397) 397
research (396) 396
rodents (389) 389
analysis (354) 354
mental depression (349) 349
mental disorders (348) 348
double-blind (344) 344
stress (340) 340
depression, mental (334) 334
adult (331) 331
behavior (326) 326
major depression (324) 324
disease models, animal (322) 322
prefrontal cortex (321) 321
biomedicine (319) 319
brain - metabolism (311) 311
neurotransmitters (310) 310
major depressive disorder (308) 308
nervous system (303) 303
schizophrenia (303) 303
hippocampus (285) 285
serotonin reuptake inhibitors (283) 283
rats, sprague-dawley (281) 281
serotonin uptake inhibitors (273) 273
serotonin transporter (269) 269
gaba (268) 268
neuroscience (266) 266
receptors (263) 263
physiological aspects (258) 258
pharmacology (256) 256
serotonin uptake inhibitors - therapeutic use (252) 252
drug therapy (251) 251
antidepressive agents - therapeutic use (250) 250
care and treatment (250) 250
obsessive-compulsive disorder (248) 248
biochemistry & molecular biology (245) 245
health aspects (241) 241
5-ht (236) 236
studies (227) 227
gene expression (226) 226
cortex (225) 225
dorsal raphe nucleus (221) 221
neurobiology (221) 221
brain - drug effects (218) 218
middle aged (218) 218
psychopharmacology (217) 217
behavior, animal - drug effects (211) 211
review (211) 211
medicine (209) 209
dose-response relationship, drug (208) 208
fluoxetine (208) 208
rats, wistar (207) 207
serotonin uptake inhibitors - pharmacology (205) 205
pharmacology/toxicology (203) 203
antidepressive agents - pharmacology (200) 200
anxieties (199) 199
rat-brain (195) 195
antidepressant (192) 192
phenols (190) 190
genetic aspects (188) 188
norepinephrine (187) 187
dopamine - metabolism (184) 184
receptor (184) 184
medicine & public health (182) 182
medial prefrontal cortex (181) 181
memory (180) 180
placebo-controlled trial (178) 178
mice, inbred c57bl (174) 174
proteins (173) 173
bipolar disorder (168) 168
in-vivo (168) 168
drugs (167) 167
risk factors (167) 167
central-nervous-system (165) 165
treatment outcome (165) 165
animal models (164) 164
research article (163) 163
amygdala (160) 160
serotonin receptors (159) 159
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3889) 3889
Japanese (13) 13
Russian (5) 5
German (4) 4
Spanish (4) 4
French (2) 2
Czech (1) 1
Italian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuroscience, ISSN 0306-4522, 2010, Volume 165, Issue 4, pp. 1390 - 1401
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 2018, Volume 24, Issue 5, pp. 726 - 745
Antidepressants that block the serotonin transporter, (Slc6a4/SERT), selective serotonin reuptake inhibitors (SSRIs) improve mood in adults but have... 
MONOAMINE-OXIDASE | SEROTONIN TRANSPORTER | EARLY-LIFE BLOCKADE | PSYCHIATRY | BIOCHEMISTRY & MOLECULAR BIOLOGY | REUPTAKE INHIBITOR ANTIDEPRESSANTS | NEUROSCIENCES | GENETIC-VARIATION | CORTEX DEVELOPMENT | DEEP BRAIN-STIMULATION | RECEPTORS | EXPRESSION | GABAERGIC NEURONS | Pyramidal Cells - metabolism | Depression - physiopathology | Male | Cerebral Cortex - metabolism | Emotions - drug effects | Depression - drug therapy | Prefrontal Cortex - drug effects | Female | Antidepressive Agents - pharmacology | Anxiety Disorders - drug therapy | Cerebral Cortex - drug effects | GABAergic Neurons - metabolism | Anxiety - metabolism | Disease Models, Animal | Serotonin Uptake Inhibitors - metabolism | Serotonin Plasma Membrane Transport Proteins - physiology | Mice, Inbred C57BL | Depressive Disorder - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Animals | Dorsal Raphe Nucleus - metabolism | Dorsal Raphe Nucleus - drug effects | Serotonin - metabolism | Prefrontal Cortex - metabolism | Mice | Serotonin Uptake Inhibitors - pharmacology | Anxiety Disorders - physiopathology | Ethylenediaminetetraacetic acid | GABA | Serotonin uptake inhibitors | Glutamate | Neurons | Synaptogenesis | Circuits | Mental depression | Drug development | Developmental stages | Antidepressants | Dorsal raphe nucleus | Raphe nuclei | Anxiety | Myelin P0 protein | Cortex (prefrontal) | Emotional behavior | Signs and symptoms | Serotonin | Fluoxetine | Pharmacology | Ablation | Mood | Serotonin transporter | Pyramidal cells | Neural networks | Adults | Glutamatergic transmission | Transporter | Synapses | Long-term effects | Life Sciences | Human health and pathology | Neurons and Cognition | Neurobiology | Pharmaceutical sciences | Psychiatrics and mental health
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 06/2006, Volume 31, Issue 6, pp. 1112 - 1122
Regulation of neurotransmission via group-III metabotropic glutamate receptors (mGluR4, -6, -7, and -8) has recently been implicated in the pathophysiology of... 
receptor | Depression | Group-III mGluR | Hypothalamic-pituitary-adrenal axis | Anxiety | 5-HT | Glutamate | hypothalamic-pituitary-adrenal axis | PSYCHIATRY | MINERALOCORTICOID-RECEPTOR | FACTOR MESSENGER-RNA | PITUITARY-ADRENOCORTICAL AXIS | group-III mGluR | ADRENAL AXIS | ANTIDEPRESSANT DRUGS | NEUROSCIENCES | anxiety | NEUROTROPHIC FACTOR EXPRESSION | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | depression | DEXAMETHASONE SUPPRESSION TEST | RAT-BRAIN | glutamate | 5-HT1A receptor | GLUCOCORTICOID NEGATIVE FEEDBACK | Brain-Derived Neurotrophic Factor - genetics | Receptor, Serotonin, 5-HT1A - genetics | Body Weight - drug effects | Male | Receptors, Glucocorticoid - metabolism | Hippocampus - drug effects | RNA, Messenger - metabolism | Body Weight - genetics | Dexamethasone - pharmacology | Reverse Transcriptase Polymerase Chain Reaction - methods | Stress, Physiological - metabolism | Immunoassay - methods | Brain-Derived Neurotrophic Factor - metabolism | Receptors, Metabotropic Glutamate - deficiency | Adrenocorticotropic Hormone - blood | Receptor, Serotonin, 5-HT1A - metabolism | Hypothalamo-Hypophyseal System - drug effects | Pituitary-Adrenal System - drug effects | Pituitary-Adrenal System - metabolism | Mice, Inbred C57BL | Gene Expression Regulation - physiology | Hypothalamo-Hypophyseal System - metabolism | Mice, Knockout | Gene Expression Regulation - drug effects | Hippocampus - metabolism | Animals | Receptors, Glucocorticoid - genetics | Glucocorticoids - pharmacology | Mice | Radioimmunoassay - methods
Journal Article
BBA - Molecular Basis of Disease, ISSN 0925-4439, 01/2019, Volume 1865, Issue 1, pp. 193 - 205
Journal Article
Journal Article
Journal of Chemical Neuroanatomy, ISSN 0891-0618, 2011, Volume 41, Issue 4, pp. 227 - 233
• Our finding shows decreases in TPH2 mRNA expression in the DRN of 5-HTT−/− mice. • Increases were observed in TPH2 mRNA levels in the DRN of VGLUT+/− mice. •... 
Glutamate vesicular transporter 1 | Serotonin transporter | Cannabinoid receptor 1 | Median raphe nucleus |